🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

127 results for “Jin” Clear

  1. Normal Saline

    Nanjing Zenshine Pharmaceuticals

    Breast Feeding

    approved small molecule completed

    1 trial

  2. Procaterol

    Otsuka Beijing Research Institute

    Asthma

    approved small molecule completed

    1 trial

  3. Qianjin Capsule of Gynaecology

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pelvic Inflammatory Diseases

    approved small molecule active

    1 trial

  4. Rebamipide

    Otsuka Beijing Research Institute

    Stomach Ulcer

    approved small molecule completed

    1 trial

  5. Tolvaptan

    Otsuka Beijing Research Institute

    Hyponatremia and Extracellular Fluid in Cirrhotic

    approved small molecule terminated

    1 trial

  6. Topiramate

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Alcohol Dependence

    approved small molecule active

    1 trial

  7. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial

  8. Xingnaojing injection

    Universal Integrated

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  9. Xingnaojing injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  10. Xuebijing

    Rocket Pharmaceuticals B.V.

    Pulmonary Disease, Chronic Obstructive

    approved small molecule active

    1 trial

  11. Xuebijing Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule completed

    2 trials

  12. aripiprazole

    Otsuka Beijing Research Institute

    Bipolar Disorder

    approved small molecule completed

    1 trial

  13. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial

  14. 18F-P3BZA

    Xijing Hospital

    Melanoma

    other active

    1 trial

  15. Aescin in Horse Chestnut

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Anorectal Disorder

    small molecule active

    1 trial

  16. Amivita

    Wujin People's Hospital

    Amyotrophic Lateral Sclerosis

    small molecule active

    1 trial

  17. CYP2C19 genotype testing

    Beijing Anzhen Hospital

    Angina, Stable

    gene therapy active

    1 trial

  18. Celastrol

    Nanjing Legend Biotech Co.

    Safety Issues

    other active

    1 trial

  19. Celastrol

    Nanjing Legend Biotech Co.

    Safety

    other active

    1 trial

  20. Corticosteroid

    Beijing Anzhen Hospital

    Heart Valve Diseases

    small molecule completed

    1 trial

  21. Folic Acid

    Xijing Hospital

    Stroke

    small molecule terminated

    1 trial

  22. Huangjing Yangji Formula Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcopenia

    small molecule active

    1 trial

  23. Intraoperative identification method

    Xijing Hospital

    Thyroid Cancer

    other active

    1 trial

  24. LCAR-M61S cells preparation

    Nanjing Legend Biotech Co.

    Relapsed/Refractory Multiple Myeloma

    mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources